Regeneron Pharmaceuticals, Inc.
IT ˙ ETLX ˙ US75886F1075
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT
SecurityIT:4REGN / Regeneron Pharmaceuticals, Inc.
InstitutionSkba Capital Management Llc
Latest Disclosed Ownership1,295 shares
Latest Disclosed Value $ 1,000,569
Skba Capital Management Llc ownership in 4REGN / Regeneron Pharmaceuticals, Inc.

On May 13, 2026 - Skba Capital Management Llc filed a 13F-HR form disclosing ownership of 1,295 shares of Regeneron Pharmaceuticals, Inc. (IT:4REGN) valued at $1,000,569 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,295 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,295 0 0.00 1,001 0.10 0.1374
2026-02-12 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 1,295 -3 -0.23 1,000 37.04 0.1419
2025-11-12 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,298 100 8.35 730 16.08 0.1009
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,198 221 22.62 629 1.45 0.0905
2025-05-13 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 977 237 32.03 620 17.46 0.0922
2025-02-12 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 740 0 0.00 527 -32.18 0.0833
2024-11-12 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 740 0 0.00 778 0.00 0.1155
2024-08-12 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 740 -15 -1.99 778 7.02 0.1248
2024-05-13 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 755 5 0.67 727 10.33 0.1136
2024-02-12 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 750 -45 -5.66 659 0.61 0.1109
2023-11-09 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 795 0 0.00 654 14.54 0.1207
2023-08-10 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 795 0 0.00 571 -12.56 0.1030
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 795 -50 -5.92 653 7.22 0.1217
2023-02-10 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 845 0 0.00 610 4.64 0.1127
2022-11-10 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 845 0 0.00 582 16.40 0.1234
2022-08-12 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 845 0 0.00 500 -15.25 0.1000
2022-05-12 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 845 0 0.00 590 10.49 0.1065
2022-02-10 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 845 0 0.00 534 4.50 0.1006
2021-11-10 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 845 0 0.00 511 8.26 0.1019
2021-08-12 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 845 100 13.42 472 34.09 0.0923
2021-05-13 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 745 145 24.17 352 21.38 0.0559
2021-02-10 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 600 10 1.69 290 -12.12 0.0486
2020-11-12 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 590 -40 -6.35 330 -16.03 0.0659
2020-08-12 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 630 -70 -10.00 393 14.91 0.0763
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 700 0 0.00 342 30.04 0.0778
2020-02-12 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 700 700 263 0.0416
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.